# Intravenous Methocarbamol for Acute Pain After Spine Surgery

> **NCT06659965** · — · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 1270 (actual)

## Conditions studied

- Acute Post Operative Pain
- Postsurgical Pain Management
- Spine Surgery
- Acute Pain, Postoperative
- Multimodal Analgesia

## Interventions

- **DRUG:** Intravenous Methocarbamol

## Key facts

- **NCT ID:** NCT06659965
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 1270 (ACTUAL)
- **Last updated:** 2025-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06659965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06659965, "Intravenous Methocarbamol for Acute Pain After Spine Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06659965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*